{"publication_id":"124c3917-ffdc-4ae1-840c-cb71641cccd7","screening":{"identified":17,"screened":17,"excluded":0,"included":17,"included_or_retained":17,"flow":["identified","screened","excluded_with_reasons","included"],"wording":"17 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit.","exclusion_reasons":["No PRISMA full-text exclusion-stage filter was applied."]},"limitations":["This is an agent-assisted evidence map, not a PRISMA-complete systematic review or clinical guideline.","It is not PROSPERO-registered and should not be read as medical advice.","Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."],"contradictions":["Evidence-boundary note: Because the retained corpus relies on absent or limited direct interventional hard-endpoint evidence and includes mixed, indirect, adjacent/mechanistic evidence, this synthesis is hypothesis-generating and not definitive. Null clinical findings and mechanistic plausibility are interpreted separately, so it does not support broad causal or policy claims; broad population-level proof is missing until direct human outcome studies replicate the signal with durable follow-up.","The conclusion is that Photobiomodulation remains a bounded geroscience case: the retained clinical and mechanistic evidence profile defines the scope for targeted testing, while mixed and null findings limit any unqualified anti-aging claim."]}